Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06150534 · ClinicalTrials.gov registry record
At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill
A clinical trial, sponsored by Takeda.
- Completed
- Registry status
- 22
- Enrollment target
NCT06150534 is a clinical trial that has completed, run by Takeda. The registered enrollment target is 22 participants.
The verdict
NCT06150534 has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The main aim of this study is to determine the impact of digital health technology, such as Alexa Skill, used to support the initiation of home-based subcutaneous immunoglobulin (SCIG) treatment, treatment management, and overall participant experience.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-12-27 |
| Est. Completion | 2025-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06150534
The ClinicalTrials.gov registry entry for NCT06150534 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT06150534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06150534 about?
NCT06150534 is a clinical study titled "At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill". The main aim of this study is to determine the impact of digital health technology, such as Alexa Skill, used to support the initiation of home-based subcutaneous immunoglobulin (SCIG) treatment, treatment management, and overall participant experience.
What is the current status of trial NCT06150534?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2023-12-27. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT06150534?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT06150534?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.